Navigation Links
Innosight Board Member Honored With Lifetime Achievement Award
Date:6/19/2012

Boston, MA (PRWEB) June 19, 2012

Innovation consulting firm Innosight announced that board member Roy Davis is the recipient of a lifetime achievement award from Global Corporate Venturing Magazine. The magazine’s annual Awards Gala and Symposium recognizes individuals and organizations for their contributions to the venture community, successful portfolio launches and sales, and industry leadership. Accepting the “Industry Legend” award, Davis was lauded for his prolific career with Johnson & Johnson and his dedication to developing new companies under the J&J banner that deliver transformational healthcare solutions.

The award celebrates Davis’ nearly three decades at Johnson & Johnson. Most recently serving as president of Johnson & Johnson Development Corporation (JJDC), he identified early market indicators, healthcare trends and strategic investment opportunities. He also led the creation of Red Script™ Ventures, designed to support the growth of external ventures and internal innovation. Under Davis’ leadership, JJDC, the venture capital subsidiary of J&J, fostered a culture of collaboration, dedicated focus, and milestone management with portfolio companies to improve the investments’ short- and long-term financial outcomes.

As a newly appointed member of Innosight’s board of directors, Davis offers a global perspective and a rich understanding of the healthcare industry. The authority on disruptive innovation, Innosight has deep healthcare expertise, helping pharmaceutical companies, medical device manufacturers and healthcare service providers leverage new business models and solutions that redefine healthcare delivery in markets around the world.

Davis also serves as a member of the Industrial Advisory Board of the Cleveland Clinic, and sits on Rosetta Genomics’ board of directors.

About Innosight
Innosight is a strategy and innovation consulting firm that helps clients achieve repeatable growth through innovation. The leading authority on disruptive innovation, Innosight collaborates with companies to devise growth strategies, develop innovation capabilities and leadership, and create new products and services that improve people’s lives. Innosight is based in Lexington, Massachusetts, with offices in Singapore and India.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9615461.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
2. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
3. GenturaDx Announces Formation of Scientific Advisory Board
4. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
5. DiaTech Life Sciences Announces Medical Advisory Board
6. BioStorage Technologies Appoints New Member to Board of Directors
7. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
8. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
9. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
10. Coalition to Save Pure Files Proxy Documents With SEC, Urges Pures Board to Set an Annual Meeting Date
11. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Innosight Board Member Honored With Lifetime Achievement Award
(Date:3/28/2017)... , March 28, 2017 Biostage, Inc. ... company developing bioengineered organ implants to treat cancers and ... today announced that Jim McGorry, CEO of ... BioEngineering panel at the MassBio 2017 Annual ... PM ET in Cambrige, Massachussetts. The 3D Printing ...
(Date:3/28/2017)... Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" or the ... from its phase 1/2 tendon repair study investigating the use ... a treatment for Achilles tendinosis. ... The clinical trial met its ... and showed no serious adverse events related to the study ...
(Date:3/27/2017)... 2017 Cousins Properties (NYSE: CUZ ) ... companies, has signed a 10-year, approximately 125,000 square-foot lease at ... located in the Westshore submarket of Tampa, FL. ... has chosen Corporate Center for their new location in ... and chief executive officer of Cousins Properties. "Amgen is a ...
(Date:3/27/2017)... 2017 The new research portal will ... of reports on Valero Energy , offering extensive market ... industries. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) The latest trend ... green. Ethanol today, even though touted as a green alternative ...
Breaking Biology Technology:
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
(Date:3/20/2017)... March 20, 2017 PMD Healthcare announces the ... and Wellness Management System (WMS), a remote, real-time lung ... 2010, PMD Healthcare is a Medical Device, Digital Health, ... dedicated to creating innovative solutions that empower people to ... intent focus, PMD developed the first ever personal spirometer, ...
(Date:3/9/2017)... VIEW, Calif. , March 9, 2017 ... 23andMe , the leading personal genetics company, are using ... now provide customers with personalized nutrition plans that consider ... but also genetic markers impacting how their body may ... food decision support platform uses biometrics such as Body ...
Breaking Biology News(10 mins):